VRX
Valeant Pharmaceuticals International Inc
Valeant Pharmaceuticals International Inc 13F Holders
VRX Stock Ownership Activity
- # of activities:
- 2
- AVG reported price*:
- $17.33
2 value investing gurus have made changes to the Valeant Pharmaceuticals International Inc (VRX) position according to the gurus' 2017 Q2 SEC quarterly report(s). The number of VRX shares has been increased by 2 super investor(s).
Which gurus or hedge funds bought VRX in 2017 Q2?
According to the 2017 Q2 SEC filing(s) Valeant Pharmaceuticals International Inc (VRX) has been bought by 2 gurus / funds: Bill Miller - Miller Value Partners (added shares +22.88%) and Francis Chou - Chou Associates Management (added shares +29.74%).
To see more about who is investing in Valeant Pharmaceuticals International Inc (VRX), please go to the VRX ownership page.
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* AVG reported price: weighted average based on position sizes. Larger holdings have proportionally more influence on the average. This doesn't represent the actual buy or sell price. It is the split-adjusted average price of the securities as of the last day of the reported period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.